Related references
Note: Only part of the references are listed.Clinical Applications for microRNAs in Cancer
S. P. Nana-Sinkam et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1
Qing Xu et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2013)
MicroRNA profiling of diagnostic needle aspirates from patients with pancreatic cancer
S. Ali et al.
BRITISH JOURNAL OF CANCER (2012)
The role of the insulin-like growth factor signaling pathway in non-small cell lung cancer and other solid tumors
Giorgio V. Scagliotti et al.
CANCER TREATMENT REVIEWS (2012)
MiR-145 modulates multiple components of the insulin-like growth factor pathway in hepatocellular carcinoma
Priscilla T. -Y. Law et al.
CARCINOGENESIS (2012)
Crizotinib for ALK-Rearranged Non-Small Cell Lung Cancer: A New Targeted Therapy for a New Target
Leena Gandhi et al.
CLINICAL CANCER RESEARCH (2012)
Targeting the insulin-like growth factor 1 receptor (IGF1R) signaling pathway for cancer therapy
Cristina E. Tognon et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
Rafael Rosell et al.
LANCET ONCOLOGY (2012)
Modulation of the Osteosarcoma Expression Phenotype by MicroRNAs
Heidi M. Namlos et al.
PLOS ONE (2012)
MiR-122 Inhibits Cell Proliferation and Tumorigenesis of Breast Cancer by Targeting IGF1R
Biyun Wang et al.
PLOS ONE (2012)
miR-486-5p Induces Replicative Senescence of Human Adipose Tissue-Derived Mesenchymal Stem Cells and Its Expression Is Controlled by High Glucose
Yeon Jeong Kim et al.
STEM CELLS AND DEVELOPMENT (2012)
Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers
Jun Shen et al.
BMC CANCER (2011)
A 5-MicroRNA Signature for Lung Squamous Cell Carcinoma Diagnosis and hsa-miR-31 for Prognosis
Xiaogang Tan et al.
CLINICAL CANCER RESEARCH (2011)
Genomic Loss of miR-486 Regulates Tumor Progression and the OLFM4 Antiapoptotic Factor in Gastric Cancer
Hue-Kian Oh et al.
CLINICAL CANCER RESEARCH (2011)
Randomized Phase II Study of Erlotinib in Combination With Placebo or R1507, a Monoclonal Antibody to Insulin-Like Growth Factor-1 Receptor, for Advanced-Stage Non-Small-Cell Lung Cancer
Suresh S. Ramalingam et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer
Mattia Boeri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
MicroRNA profiling reveals that miR-21, miR486 and miR-214 are upregulated and involved in cell survival in Sezary syndrome
M. G. Narducci et al.
CELL DEATH & DISEASE (2011)
Exciting New Targets in Lung Cancer Therapy: ALK, IGF-1R, HDAC, and Hh
Joel W. Neal et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2010)
Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers
Lei Yu et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Insulin-like Growth Factor Receptor 1 (IGF1R) Gene Copy Number Is Associated With Survival in Operable Non-Small-Cell Lung Cancer: A Comparison Between IGF1R Fluorescent In Situ Hybridization, Protein Expression, and mRNA Expression
Rafal Dziadziuszko et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Serum MicroRNA Signatures Identified in a Genome-Wide Serum MicroRNA Expression Profiling Predict Survival of Non-Small-Cell Lung Cancer
Zhibin Hu et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Regulation of PI3-kinase/Akt signaling by muscle-enriched microRNA-486
Eric M. Small et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Safety, Pharmacokinetics, and Pharmacodynamics of the Insulin-Like Growth Factor Type 1 Receptor Inhibitor Figitumumab (CP-751,871) in Combination with Paclitaxel and Carboplatin
Daniel D. Karp et al.
JOURNAL OF THORACIC ONCOLOGY (2009)
Causes and consequences of microRNA dysregulation in cancer
Carlo M. Croce
NATURE REVIEWS GENETICS (2009)
Novel Rank-Based Statistical Methods Reveal MicroRNAs with Differential Expression in Multiple Cancer Types
Roy Navon et al.
PLOS ONE (2009)
Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells
Bin Shi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
miR-15 and miR-16 induce apoptosis by targeting BCL2
A Cimmino et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
GA Calin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The new kid on the block(ade) of the IGF-1 receptor
D LeRoith et al.
CANCER CELL (2004)
Role of the insulin-like growth factor family in cancer development and progression
H Yu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)